English | Español

Regulatory

+ Regulatory
Press release submission | Dec 6, 2018

JANSSEN: DARZALEX® (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma
+ Technology/Innovation
Press release submission | Dec 5, 2018

NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
+ Community
Marian Johns | Dec 1, 2018

UC San Diego Health names Padres team doctor as chief of sports medicine
+ Technology/Innovation
Press release submission | Nov 26, 2018

OBI PHARMA INC.: Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
+ Regulatory
Press release submission | Nov 26, 2018

ABBVIE: Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
+ Technology/Innovation
Press release submission | Nov 19, 2018

ALLEN TECHNOLOGIES: Hunt Regional Medical Center Improving Patient Experience with Allen’s Interactive Patient Engagement Solution
+ Technology/Innovation
Press release submission | Nov 19, 2018

AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS: Patients with shoulder arthritis have new options to avoid risks of total shoulder replacement
+ Community
Marian Johns | Nov 15, 2018

University of Pittsburgh cancer center among few to offer immunotherapy for non-Hodgkin lymphoma

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones